Creso Pharma (CPH.ASX) puts retail bagholders to the sword with PharmaCielo (PCLO.V) deal
The CPH circus looks to be leaving town after Canadian listed PharmaCielo (PCLO.V) made an all-scrip AUD $122M offer to acquire Creso Pharma (CPH.ASX), which equated to AUD 0.63 per share when the deal was announced.